Treatment Options in Patients Suffering from Hemolytic-Uremic Syndrome: The Serbian Military Medical Academy Experience

Published Online: Sep 20, 2022

Page range: 237 - 242

Received: Jun 27, 2019

Accepted: Sep 16, 2019

DOI: https://doi.org/10.2478/sjecr-2019-0060

Keywords

Hemolytic-uremic syndrome, atypical hemolytic-uremic syndrome, C3, corticosteroids, plasmapheresi

© 2022 Jelena Tadic et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.